Difference between revisions of "Part:BBa K382030"
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
| − | |||
__NOTOC__ | __NOTOC__ | ||
<partinfo>BBa_K382030 short</partinfo> | <partinfo>BBa_K382030 short</partinfo> | ||
| − | Protein domain that heterodimerizes with | + | Protein domain that heterodimerizes with ecdysone receptor (BBa_K382033) in the presence of methyoxyfenozide. |
Human RxR has been shown to be sensitive to lower level of methoxyfenozide than Locust RxR, but also to have higher background activation in the absence of methoxyfenozide. | Human RxR has been shown to be sensitive to lower level of methoxyfenozide than Locust RxR, but also to have higher background activation in the absence of methoxyfenozide. | ||
Latest revision as of 23:22, 26 October 2010
RxRhm (Retinoic Acid Receptor)
Protein domain that heterodimerizes with ecdysone receptor (BBa_K382033) in the presence of methyoxyfenozide.
Human RxR has been shown to be sensitive to lower level of methoxyfenozide than Locust RxR, but also to have higher background activation in the absence of methoxyfenozide.
Sequence and Features
Assembly Compatibility:
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]